| 注册
首页|期刊导航|北京大学学报(医学版)|抗Jo-1抗体在特发性炎性肌病临床分层及疾病谱中的意义

抗Jo-1抗体在特发性炎性肌病临床分层及疾病谱中的意义

李嘉辰 李玉慧 赖展鸿 邵苗 金月波 高小娟 张科 侯儆 张燕英 栗占国

北京大学学报(医学版)2023,Vol.55Issue(6):958-965,8.
北京大学学报(医学版)2023,Vol.55Issue(6):958-965,8.DOI:10.19723/j.issn.1671-167X.2023.06.002

抗Jo-1抗体在特发性炎性肌病临床分层及疾病谱中的意义

Significance of anti-Jo-1 antibody's clinical stratification in idiopathic inflammatory myopathy and disease spectrum

李嘉辰 1李玉慧 1赖展鸿 1邵苗 1金月波 1高小娟 2张科 3侯儆 4张燕英 5栗占国1

作者信息

  • 1. 北京大学人民医院风湿免疫科,北京 100044
  • 2. 宁德师范学院附属宁德市医院风湿免疫科,福建宁德 352199
  • 3. 中国人民解放军第80集团军医院内分泌科,山东潍坊 261000
  • 4. 张家口市第一医院肾内科,河北张家口 075041
  • 5. 深圳市中医院风湿病科,深圳 518033
  • 折叠

摘要

Abstract

Objective:To investigate the significance of anti-histidyl tRNA synthetase(Jo-1)antibody in idiopathic inflammatory myopathies(IIM)and its diseases spectrum.Methods:We enrolled all the patients who were tested positive for anti-Jo-1 antibody by immunoblotting in Peking University People's Hospital between 2016 and 2022.And the patients diagnosed with anti-synthetase antibody syndrome(ASS)with negative serum anti-Jo-1 antibody were enrolled as controls.We analyzed the basic informa-tion,clinical characteristics,and various inflammatory and immunological indicators of the patients at the onset of illness.Results:A total of 165 patients with positive anti-Jo-1 antibody were enrolled in this study.Among them,80.5%were diagnosed with connective tissue disease.And 57.6%(95/165)were diagnosed with IIM,including ASS(84/165,50.9%),immune-mediated necrotizing myopathy(7/165,4.2%)and dermatomyositis(4/165,2.4%).There were 23.0%(38/165)diagnosed with other connective tissue disease,mainly including rheumatoid arthritis(11/165,6.7%),undifferentiated connective tissue disease(5/165,3.0%),interstitial pneumonia with autoimmune features(5/165,3.0%),undifferentiated arthritis(4/165,2.4%),Sjögren's syndrome(3/165,1.8%),systemic lu-pus erythematosus(3/165,1.8%),systemic vasculitis(3/165,1.8%),and so on.Other cases in-cluded 3(1.8%)malignant tumor patients,4(2.4%)infectious cases and so on.The diagnoses were not clear in 9.1%(15/165)of the cohort.In the analysis of ASS subgroups,the group with positive se-rum anti-Jo-1 antibody had a younger age of onset than those with negative serum anti-Jo-1 antibody(49.9 years vs.55.0 years,P=0.026).Clinical manifestations of arthritis(60.7%vs.33.3%,P=0.002)and myalgia(47.1%vs.22.2%,P=0.004)were more common in the ASS patients with posi-tive anti-Jo-1 antibody.With the increase of anti-Jo-1 antibody titer,the incidence of the manifestations of arthritis,mechanic hands,Gottron sign and Raynaud phenomenon increased,and the proportion of ab-normal creatine kinase and α-hydroxybutyric dehydrogenase index increased in the ASS patients.The in-cidence of myalgia and myasthenia were significantly more common in this cohort when anti-Jo-1 antibody-positive ASS patients were positive for one and more myositis specific antibodies/myositis associated autoantibodies(P<0.05).Conclusion:The disease spectrum in patients with positive serum anti-Jo-1 antibody includes a variety of diseases,mainly ASS.And anti-Jo-1 antibody can also be found in many connective tissue diseases,malignant tumor,infection and so on.

关键词

抗组氨酰tRNA合成酶抗体/抗合成酶综合征/结缔组织病

Key words

Anti-histidyl tRNA synthetase antibody/Anti-synthetase syndrome/Connective tissue disease

分类

医药卫生

引用本文复制引用

李嘉辰,李玉慧,赖展鸿,邵苗,金月波,高小娟,张科,侯儆,张燕英,栗占国..抗Jo-1抗体在特发性炎性肌病临床分层及疾病谱中的意义[J].北京大学学报(医学版),2023,55(6):958-965,8.

基金项目

国家自然科学基金(82371804)、北京市自然科学基金海淀原始创新联合基金项目(L222017)、北京大学人民医院研究与发展基金(RDX2023-03)Supported by the National Natural Science Foundation of China(82371804),Beijing Natural-Science Foundation(L222017),Peking University People's Hospital Research and Development Foundation(RDX2023-03) (82371804)

北京大学学报(医学版)

OA北大核心CSCDCSTPCD

1671-167X

访问量0
|
下载量0
段落导航相关论文